Vaccinex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Vaccinex and buy or sell other stocks, ETFs, and their options commission-free!About VCNX
Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders.
CEOMaurice Zauderer
CEOMaurice Zauderer
Employees43
Employees43
HeadquartersRochester, New York
HeadquartersRochester, New York
Founded1997
Founded1997
Employees43
Employees43
VCNX Key Statistics
Market cap45.63M
Market cap45.63M
Price-Earnings ratio-3.92
Price-Earnings ratio-3.92
Dividend yield—
Dividend yield—
Average volume708.49K
Average volume708.49K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.824
52 Week high$0.824
52 Week low$0.11
52 Week low$0.11
Stock Snapshot
The current Vaccinex(VCNX) stock price is $0.64, with a market capitalization of 45.63M. The stock trades at a price-to-earnings (P/E) ratio of -3.92.
Vaccinex(VCNX) stock opened on 2025-11-07 at —. The price climbed to — and dipped to —.
The Vaccinex(VCNX)'s current trading volume is 0, compared to an average daily volume of 708.49K.
During the past year, Vaccinex(VCNX) stock moved between $0.11 at its lowest and $0.82 at its peak.
During the past year, Vaccinex(VCNX) stock moved between $0.11 at its lowest and $0.82 at its peak.
People also own
Based on the portfolios of people who own VCNX. This list is generated using Robinhood data, and it’s not a recommendation.